Russian Covid-19 Vaccine | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
May 09, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, MAY 09, 2025

Russian Covid-19 Vaccine

Syria's President Bashar al-Assad speaks as he meets with the Syrian cabinet in Damascus, Syria in this handout picture released by Sana on March 30, 2021. SANA/Handout via REUTERS
Coronavirus chronicle

Syria receives first shipment of Russian shots - report

Ambassador Riad Haddad did not say how big the shipment was but said the vaccine was now being administered to the public after doctors and the country's senior leaders were among those to get...

Women wearing protective face masks walk amid the rush of people along a road as the outbreak of the coronavirus disease (COVID-19) continues, in Karachi, Pakistan July 20, 2020. Photo: Reuters
Coronavirus chronicle

Young Pakistanis rush to purchase Russian vaccine as private sales open

FILE PHOTO: Biomedical engineers pack a consignment of AstraZeneca/Oxford vaccines under the COVAX scheme against coronavirus disease (Covid-19), before distribution at the Kitengela cold rooms stores in Kitengela, outside Nairobi, Kenya March 4, 2021. REUTERS/Monicah Mwangi
Coronavirus chronicle

Africa proves rocky terrain for Russian and Chinese vaccines

FILE PHOTO: A medical specialist holds a vial of Sputnik V vaccine against the coronavirus in a department store in Moscow, Russia, January 18, 2021 REUTERS/Shamil Zhumatov
Coronavirus chronicle

EU says no talks under way to buy Russia's Covid-19 vaccine

FILE PHOTO: A handout photo shows an employee demonstrating vials with "Gam-Covid-Vac" vaccine against the coronavirus disease (Covid-19), developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), during its production at Binnopharm pharmaceutical company in Zelenograd near Moscow, Russia August 7, 2020. Picture taken August 7, 2020. The Russian Direct Investment Fund (RDIF)/Andrey Rudakov/Handout via REUTERS
Coronavirus chronicle

EU regulator says Russia yet to submit Covid-19 vaccine application

A shipment of doses of the Sputnik V (Gam-Covid-Vac) vaccine against the coronavirus disease (Covid-19) is seen after arriving at Ezeiza International Airport, in Buenos Aires, Argentina January 28, 2021. REUTERS/Agustin Marcarian/File Photo
Coronavirus chronicle

Pakistan approves Russia's Sputnik-V Covid-19 vaccine for emergency use

The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said in a statement.  Photo: Reuters
Coronavirus chronicle

Russia applies for registration of Covid-19 vaccine in Europe

A nurse prepares Russia's "Sputnik-V" vaccine for inoculation in a post-registration trials stage at a clinic in Moscow. Photo: Reuters
Coronavirus chronicle

Russia says 1.5 million vaccinated globally with Sputnik

Russia to test new Covid-19 antibody drug in new year
Coronavirus chronicle

Russia to test new Covid-19 antibody drug in new year

FILE PHOTO: A nurse shows Russia's "Sputnik-V" vaccine against the coronavirus disease (Covid-19) prepared for inoculation in a post-registration trials stage at a clinic in Moscow, Russia September 17, 2020. REUTERS/Tatyana Makeyeva/File Photo
Coronavirus chronicle

Russian state employees describe pressure to join vaccine trials

The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said in a statement.  Photo: Reuters
Coronavirus chronicle

Russia claims Sputnik V Covid-19 vaccine is 95% effective

Russia's Covid-19 vaccine trial paused as clinics run short of shots
Coronavirus chronicle

Russia's Covid-19 vaccine trial paused as clinics run short of shots

A handout photo provided by the Russian Direct Investment Fund (RDIF) shows samples of a vaccine against the coronavirus disease (Covid-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, Russia August 6, 2020. Picture taken August 6, 2020. The Russian Direct Investment Fund (RDIF)/Handout via REUTERS
Coronavirus chronicle

India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks - exec

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net